Is a complete VCRE research report available?

No complete published report is available for Vicore Pharma Holding AB (publ) (VCRE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Vicore Pharma Holding AB (publ) (VCRE)

NASDAQ: VCRE · USD

$9.57

+0.22 (+2.3%)· Recorded snapshot

Market cap	275.7M
Revenue (ttm)	412.1K
Net income (ttm)	-51.8M
EPS (ttm)	-$1.92
Shares out	281.5M
Volume	14,360
Beta	0.09

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 412.1K
Net income (ttm): -51.8M
EPS (ttm): -$1.92
Market cap: 275.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Metric	Value
Amount currency	USD
CIK code	0002124403
Company name	Vicore Pharma Holding AB (publ)
Country	Sweden
Country code	US
CUSIP number	92581R104
Earnings date	2026-11-05
Employees	46
Employees change	13
Employees growth	39.39%
Enterprise value	$184.5M
Exchange	NASDAQ
Financial currency	SEK
Financial report date	2026-06-30
First seen	2026-07-12
Fiscal year end	December
Founded	2000
Industry	Biotechnology
Is primary listing	No
Is SPAC	No
ISIN number	US92581R1041
Last earnings date	2026-08-21
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$275.7M
Market cap category	Micro-Cap
Next earnings date	2026-11-05
Options	No
Price	$9.57
Price currency	USD
Sector	Healthcare
Stock price date	2026-10-28
Symbol	VCRE
Website	https://www.vicorepharma.com

Metric

Value

Amount currency

USD

CIK code

0002124403

Company name

Vicore Pharma Holding AB (publ)

Country

Sweden

Country code

CUSIP number

92581R104

Earnings date

2026-11-05

Employees

Employees change

Employees growth

39.39%

Enterprise value

$184.5M

Exchange

NASDAQ

Financial currency

SEK

Financial report date

2026-06-30

First seen

2026-07-12

Fiscal year end

December

Founded

2000

Industry

Biotechnology

Is primary listing

Is SPAC

ISIN number

US92581R1041

Last earnings date

2026-08-21

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$275.7M

Market cap category

Micro-Cap

Next earnings date

2026-11-05

Options

Price

$9.57

Price currency

USD

Sector

Healthcare

Stock price date

2026-10-28

Symbol

VCRE

Website

https://www.vicorepharma.com

Metric	Value
Earnings yield	-20.08%
EV/Sales	432.7x
FCF / EV yield	-25.81%
FCF yield	-17.08%
Forward EV/Sales	1,132.12x
Forward P/S	1,710.84x
P/B ratio	3.06x
P/S ratio	653.89x
Price / tangible book value	3.06x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-20.08%

EV/Sales

432.7x

FCF / EV yield

-25.81%

FCF yield

-17.08%

Forward EV/Sales

1,132.12x

Forward P/S

1,710.84x

P/B ratio

3.06x

P/S ratio

653.89x

Price / tangible book value

3.06x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
Gross margin	100%
Operating margin	-13,116.96%
Pretax margin	-12,563.26%
Profit per employee	$-1.1M
Revenue per employee	$8,959
ROA	-34.35%
ROA (5Y)	-34.77%
ROCE	-61.14%
ROE	-56.99%
ROE (5Y)	-62.78%
ROIC	-37.17%
Tax / revenue	6.48%

Metric

Value

Gross margin

100%

Operating margin

-13,116.96%

Pretax margin

-12,563.26%

Profit per employee

$-1.1M

Revenue per employee

$8,959

ROA

-34.35%

ROA (5Y)

-34.77%

ROCE

-61.14%

ROE

-56.99%

ROE (5Y)

-62.78%

ROIC

-37.17%

Tax / revenue

6.48%

Metric	Value
EPS growth years	0
Gross profit growth	-48.4%
Gross profit growth (Q)	26.75%
Net income growth years	0
Revenue growth	-48.41%
Revenue growth (Q)	26.75%
Revenue growth (QoQ)	267.61%
Revenue growth 10Y	16.24%
Revenue growth years	0

Metric

Value

EPS growth years

Gross profit growth

-48.4%

Gross profit growth (Q)

26.75%

Net income growth years

Revenue growth

-48.41%

Revenue growth (Q)

26.75%

Revenue growth (QoQ)

267.61%

Revenue growth 10Y

16.24%

Revenue growth years

Metric	Value
EBIT	$-54.1M
EPS	$-1.92
FCF per share	$-0.16
Financing cash flow	$44.4M
Free cash flow	$-46M
Gross profit	$412,092
Income taxes	$26,723
Investing cash flow	$10.3M
Net cash flow	$7.9M
Net income	$-51.8M
Operating income	$-54.1M
Revenue	$412,092

Metric

Value

EBIT

$-54.1M

EPS

$-1.92

FCF per share

$-0.16

Financing cash flow

$44.4M

Free cash flow

$-46M

Gross profit

$412,092

Income taxes

$26,723

Investing cash flow

$10.3M

Net cash flow

$7.9M

Net income

$-51.8M

Operating income

$-54.1M

Revenue

$412,092

Metric	Value
Book value per share	$0.31
Debt / equity	0
Long-term assets	$2.6M
Long-term liabilities	$506,295
Net cash (debt)	$93.4M
Net cash / market cap	34.68%
Net cash growth	-3.34%
Net debt / equity	-1.06
Piotroski F-Score	1
Shareholders' equity	$88.1M
Tangible book value	$88.1M
Tangible book value per share	$0.31
Total assets	$95.9M
Total cash	$93.4M
Total debt	$0
Total liabilities	$7.9M
WACC	4.75%

Metric

Value

Book value per share

$0.31

Debt / equity

Long-term assets

$2.6M

Long-term liabilities

$506,295

Net cash (debt)

$93.4M

Net cash / market cap

34.68%

Net cash growth

-3.34%

Net debt / equity

-1.06

Piotroski F-Score

Shareholders' equity

$88.1M

Tangible book value

$88.1M

Tangible book value per share

$0.31

Total assets

$95.9M

Total cash

$93.4M

Total debt

Total liabilities

$7.9M

WACC

4.75%

Metric	Value
Asset turnover	0
Current assets	$93.3M
Current liabilities	$7.4M
Current ratio	12.68
Net working capital	$-5.4M
Quick ratio	12.5
Working capital	$88M
Working capital turnover	0

Metric

Value

Asset turnover

Current assets

$93.3M

Current liabilities

$7.4M

Current ratio

12.68

Net working capital

$-5.4M

Quick ratio

12.5

Working capital

$88M

Working capital turnover

Metric	Value
Buyback yield / dilution	-32.83%
Dividend yield	0%
Shareholder yield	-32.83%

Metric

Value

Buyback yield / dilution

-32.83%

Dividend yield

Shareholder yield

-32.83%

Metric	Value
1D price change	2.3%
1M price change	-0.52%
1M total return	-0.52%
1W price change	6.67%
1W total return	6.67%
20-day SMA	$9.18
3M price change	-13.2%
3M total return	-13.2%
50-day SMA	$10.23
52-week high	$17.80
52-week high date	2026-07-07
52-week low	$7.88
52-week low date	2026-10-07
All-time high	$17.80
All-time high date	2026-07-07
All-time low	$7.88
All-time low date	2026-10-07
Average true range (ATR)	$0.67
Average volume	26.3K
Beta (5Y)	0.09
Change from 52-week high	-46.26%
Change from 52-week low	21.38%
Change from all-time high	-46.07%
Change from all-time low	21.83%
Change from open	-0.67%
Day's gap	2.99%
Dollar volume	$137,353
High price	$9.63
Low price	$9.57
Monthly RSI	0
Open price	$9.63
Position in 52-week range	0%
Premarket change	2.14%
Premarket close	$9.35
Premarket price	$9.55
Premarket volume	196
Previous close	$9.35
Price vs 20-day SMA	4.63%
Price vs 50-day SMA	-6.14%
Relative volume	0.55
RSI	50.01
Sharpe ratio	-3.06
Sortino ratio	-3.67
Volume	14.4K
Weekly RSI	30.55

Metric

Value

1D price change

2.3%

1M price change

-0.52%

1M total return

-0.52%

1W price change

6.67%

1W total return

6.67%

20-day SMA

$9.18

3M price change

-13.2%

3M total return

-13.2%

50-day SMA

$10.23

52-week high

$17.80

52-week high date

2026-07-07

52-week low

$7.88

52-week low date

2026-10-07

All-time high

$17.80

All-time high date

2026-07-07

All-time low

$7.88

All-time low date

2026-10-07

Average true range (ATR)

$0.67

Average volume

26.3K

Beta (5Y)

0.09

Change from 52-week high

-46.26%

Change from 52-week low

21.38%

Change from all-time high

-46.07%

Change from all-time low

21.83%

Change from open

-0.67%

Day's gap

2.99%

Dollar volume

$137,353

High price

$9.63

Low price

$9.57

Monthly RSI

Open price

$9.63

Position in 52-week range

Premarket change

2.14%

Premarket close

$9.35

Premarket price

$9.55

Premarket volume

196

Previous close

$9.35

Price vs 20-day SMA

4.63%

Price vs 50-day SMA

-6.14%

Relative volume

0.55

RSI

50.01

Sharpe ratio

-3.06

Sortino ratio

-3.67

Volume

14.4K

Weekly RSI

30.55

Metric	Value
Float	200.8M
Float percentage	71.33%
Shares change (QoQ)	0%
Shares change (YoY)	32.83%
Shares held by insiders	4.89%
Shares held by institutions	33.51%
Shares outstanding	281.5M
Short % of float	0%
Short % of shares	0%
Short ratio	0.1 days

Metric

Value

Float

200.8M

Float percentage

71.33%

Shares change (QoQ)

Shares change (YoY)

32.83%

Shares held by insiders

4.89%

Shares held by institutions

33.51%

Shares outstanding

281.5M

Short % of float

Short % of shares

Short ratio

0.1 days

Vicore Pharma Holding AB (publ) (VCRE)

Price

Financial snapshot

Fair-value bridge

Latest news · VCRE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VCRE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VCRE

Frequently asked questions